Table 9 Study ID and phenotype ID from Table 8
Disease | Study ID (HGVST) | Study name (GWAS) | Phenotype ID (HGVPM) | Phenotype property | Title (phenotype HGVPM) |
|---|---|---|---|---|---|
Rheumatoid arthritis | 27 | Rheumatoid arthritis | 38 | Anti-cyclic citrullinated peptide-positive rheumatoid arthritis | 38: Stage 1 anti-CCP-positive rheumatoid arthritis status |
185 | Rheumatoid arthritis in the Spanish population | 235 | Rheumatoid arthritis | 235: Rheumatoid arthritis | |
Obese | 640 | Body mass index | 1111 | Body mass index | 1111: Phenotype method for body mass index |
308 | Adult body mass index in a British population | 564 | Body mass index | 564: Adult body mass index measurement | |
641 | Meta-analysis of 32 genome-wide association studies for waist-hip ratio adjusted for body mass index | 1114 | Waist-hip ratio | 1114: Phenotype method for waist-hip ratio | |
Diabetes | 463 | Glycemic traits | 825 | Fasting glucose-related: fasting plasma glucose | 825: Phenotype method for fasting glucose-related: fasting plasma glucose |
463 | Glycemic traits | 827 | Fasting glucose-related: homeostatic model assessment of beta-cell function | 827: Phenotype method for fasting glucose-related: homeostatic model assessment of beta-cell function | |
463 | Glycemic traits | 822 | Fasting insulin-related: fasting insulin | 822: Phenotype method for fasting insulin-related: fasting insulin | |
463 | Glycemic traits | 826 | Fasting insulin-related: homeostatic model assessment of insulin resistance | 826: Phenotype method for fasting insulin-related: homeostatic model assessment of insulin resistance | |
618 | Glycated hemoglobin levels | 1081 | Glycated hemoglobin levels | 1081: Phenotype method for glycated hemoglobin levels | |
313 | Log10 glycosylated hemoglobin in a British population | 569 | Log10 glycosylated hemoglobin | 569: Log10 glycosylated hemoglobin measurement | |
433 | Glucose levels 2Â h after an oral glucose challenge | 769 | 2-h glucose challenge | 769: Phenotype method for 2-h glucose challenge | |
5 | Type II diabetes mellitus | 4 | Type II diabetes | 4: T2D status | |
3 | Type II diabetes mellitus | 5 | Type II diabetes | 5: T2D status | |
52 | Type II diabetes mellitus in American Indians | 74 | Early onset type II diabetes mellitus | 74: Phenotype method forearly onset type II diabetes mellitus | |
907 | Proinsulin levels | 1538 | Proinsulin levels | 1538: Phenotype method for proinsulin levels | |
1827 | Metabolite quantitative traits | 3639 | a-Glucose | 3639: Phenotype method for a-glucose | |
Metabolic vascular disease | 312 | Serum cholesterol levels in a British population | 568 | Serum cholesterol | 568: Serum cholesterol measurement |
1827 | Metabolite quantitative traits | 3602 | Lipids (CH3) | 3602: Phenotype method for Lipids (CH3) | |
1827 | Metabolite quantitative traits | 3611 | Lipids (CH2) | 3611: Phenotype method for Lipids (CH2) | |
1827 | Metabolite quantitative traits | 3616 | Lipids (CH2CO) | 3616: Phenotype method for Lipids (CH2CO) | |
1827 | Metabolite quantitative traits | 3640 | Lipids (CH=CH*CH2CH2) | 3640: Phenotype method for Lipids (CH=CH*CH2CH2) | |
307 | Systolic blood pressure in a British population | 563 | Systolic blood pressure | 563: Systolic blood pressure measurement |